Showing results (61-70 of 396) with videos related to

Sort By:
Pageof 40
The Journal of Investigative Dermatology|January 6, 2012
Melanoma: new insights and new therapiesVasiliki A Nikolaou, Alexander J Stratigos, Keith T Flaherty, et al.
Nature Reviews. Clinical Oncology|April 5, 2017
Targeted agents and immunotherapies: optimizing outcomes in melanomaJason J Luke, Keith T Flaherty, Antoni Ribas, et al.
Nature Reviews. Cancer|November 6, 2015
Precision medicine for cancer with next-generation functional diagnosticsAdam A Friedman, Anthony Letai, David E Fisher, et al.
Cancer Discovery|September 3, 2016
High-Throughput Testing of Novel-Novel Combination Therapies for Cancer: An Idea Whose Time Has ComeUciane K Scarlett, Dennis C Chang, Thomas J Murtagh, et al.
JAMA Ophthalmology|June 17, 2016
Subretinal Fluid Associated With MEK Inhibitor Use in the Treatment of Systemic CancerMarissa L Weber, Michelle C Liang, Keith T Flaherty, et al.
Hematology/Oncology Clinics of North America|May 26, 2009
Drug targeting of oncogenic pathways in melanomaLeslie A Fecher, Ravi K Amaravadi, Lynn M Schuchter, et al.
Biochemical Society Transactions|August 12, 2014
One Hippo and many masters: differential regulation of the Hippo pathway in cancerDavid Romano, David Matallanas, Dennie T Frederick, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2003
Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancyKeith T Flaherty, James P Stevenson, Stephen M Hahn, et al.
The Journal of Investigative Dermatology|October 14, 2011
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibitionZhenyu Ji, Ching Ni Njauw, Michael Taylor, et al.
JCO Oncology Practice|January 25, 2021
REDCap-Based Operational Tool to Guide Care Coordination in a Multidisciplinary Cutaneous Oncology ClinicFarees Saqlain, Sophia Z Shalhout, Keith T Flaherty, et al.
Pageof 40